Katherine Bergman

Scientist I at Lyndra Therapeutics

Katherine Bergman has a diverse work experience spanning multiple companies and roles. Katherine is currently a Scientist I at Lyndra Therapeutics since July 2021. Prior to this, they worked at Lonza from March 2018 to November 2020, where they held the positions of Scientist II and Scientist. In these roles, Katherine utilized accelerated stability testing models and impurity analysis to predict the stability of drug product candidates. Katherine also contributed to improving data quality and integrity and increasing on-time deliveries of high-quality data to clients. Before Lonza, Katherine worked at Bend Research, a division of Capsugel, as an Associate Research Chemist from February 2016 to January 2018. Katherine also has experience as a Research Assistant at the Colorado School of Mines from June 2015 to December 2015, where they focused on synthesizing hydroxyapatite nanorods for bone regenerative purposes. Additionally, Katherine worked as a Parking Enforcement Officer/Desk Assistant and Stockroom Assistant at the Colorado School of Mines from August 2013 to December 2015. Overall, Katherine's work experience showcases their expertise in scientific research, data analysis, and project management.

Katherine Bergman attended the Colorado School of Mines from 2012 to 2015, where they obtained a Bachelor's Degree in Biochemistry. Katherine focused their studies specifically in the field of Biochemistry during this time.

Location

Lexington, United States

Links


Org chart

No direct reports

Teams


Offices


Lyndra Therapeutics

Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.


Industries

Employees

51-200

Links